You can find the annual or quarterly income statement of Nervgen Pharma Ord Shs here for insights into the performance and operational efficiency of Nervgen Pharma Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

Total revenue

--74.79K

--44.33K

Operating expenses

----

--4.60M

R&D expenses

--3.49M

--2.58M

Depreciation, depletion, and amortization

----

--10.03K

Operating profit

----

---4.60M

Net non-operating interest income (expenses)

Non-operating interest income

--74.79K

--44.33K

Gains from sale of securities

--21.83K

---230.88K

Special income (expenses)

--4.11M

---14.55M

Income before tax

----

---19.34M

Income after tax

----

---19.34M

Net income from continuous operations

---1.20M

---19.34M

Net income attributable to controlling interests

---1.20M

---19.34M

Net income attributable to common shareholders

---1.20M

---19.34M

Basic earnings per share

---0.01

---0.26

Diluted earnings per share

---0.02

---0.26

Dividend per share

----

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

